FDA approves Endurant II AUI graft stent (Medtronic) for Abdominal Aortic or Aorto-iliac Aneurysms

The FDA has given approval for the Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System, from Medtronic, for infrarenal Abdominal Aortic or Aorto-iliac Aneurysms. It is indicated for the primary endovascular treatment of infrarenal abdominal aortic or aorto-iliac aneurysms in patients whose anatomy does not allow for the use of a bifurcated device. Both the bifurcated and AUI configurations of the Endurant Stent Graft System provide a new pathway for blood flow through the iliac arteries in abdominal aortic aneurysms, thereby reducing risk of aneurysm rupture. Whereas use of the bifurcated device requires access to both iliac arteries, the AUI device requires access to only one iliac artery.